Showing results (1-10 of 223) with videos related to
Sort By:
Pageof 23
NEJM Evidence|February 6, 2024
Two Milestone Studies in Liver Cancer ImmunotherapyTim F Greten, Cecilia MongeCancer Medicine|December 21, 2023
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 yearsCecilia Monge, Tim F GretenHepatic Oncology|January 30, 2025
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscapeJoy A Awosika, Cecilia Monge, Tim F GretenJournal of Racial and Ethnic Health Disparities|September 23, 2024
Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United StatesGabriela Arroyo Figueroa, Tim F Greten, Cecilia Monge BonillaJournal of Hepatocellular Carcinoma|June 9, 2021
Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular CarcinomaCecilia Monge, Changqing Xie, Seth M Steinberg, et al.JCO Global Oncology|March 13, 2025
Disparities in Cholangiocarcinoma Research and Trials: Challenges and Opportunities in the United StatesOyepeju F Abioye, Rebekah Kaufman, Tim F Greten, et al.Journal of Hepatocellular Carcinoma|August 3, 2023
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United StatesCecilia Monge, J Alberto Maldonado, Katherine A McGlynn, et al.Carcinogenesis|July 10, 2023
The current landscape of therapies for hepatocellular carcinomaKelley Coffman-D'Annibale, Changqing Xie, Donna M Hrones, et al.The Journal of Experimental Medicine|April 20, 2019
Gender disparity in HCC: Is it the fat and not the sex?Tim F GretenPageof 23